ask="0.3800"
ask_size="5800"
average_daily_volume="1797320"
bid="0.2900"
bid_size="2000"
book_value="0.1680"
change="+0.0034"
change_from_200_day_moving_average="-0.0330"
change_from_50_day_moving_average="0.0081"
change_from_52_week_high="-0.8067"
change_From_52_week_low="0.0333"
change_in_percent="+1.0971%"
close="0.3133"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.3213"
high_52_weeks="1.1200"
last_trade_date="2/3/2017"
last_trade_price="0.3133"
last_trade_size="41941"
last_trade_time="4:00pm"
low="0.3000"
low_52_weeks="0.2800"
market_capitalization="80.56M"
moving_average_200_day="0.3463"
moving_average_50_day="0.3052"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.3070"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-9.5186%"
percent_change_from_50_day_moving_average="+2.6701%"
percent_change_from_52_week_high="-72.0268%"
percent_change_from_52_week_low="+11.8929%"
previous_close="0.3099"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.8446"
price_per_sales="1.4629"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.3300"
stock_exchange="NCM"
symbol="PPHM"
volume="3581563"
weeks_range_52="0.2800 - 1.1200"
